Seelos Therapeutics Inc (NASDAQ:SEEL)
| 0.8045 Delayed Data As of Jan 27 |  -0.0328 / -3.92%Today’s Change | 0.48 Today|||52-Week Range 1.52 | +18.48% Year-to-Date |
Latest SEEL News | Press Releases
No recent news for Seelos Therapeutics Inc.
Today’s Trading
| Previous close | 0.84 |
| Today’s open | 0.83 |
| Day’s range | 0.79 - 0.84 |
| Volume | 6,159 |
| Average volume (3 months) | 653,637 |
| Market cap | $89.0M |
Data as of 3:27pm ET, 01/27/2023
Growth & Valuation
| Earnings growth (last year) | -70.31% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 1.53 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| PRTGPortage Biotech Inc | -0.16 | -3.02% |
| FIXXHomology Medicines I... | -0.03 | -1.96% |
| CODXCo-Diagnostics Inc | 0.00 | 0.00% |
| SYRSSyros Pharmaceutical... | 0.00 | 0.00% |
Data as of 3:59pm ET, 01/27/2023
Financials
| Next reporting date | March 3, 2023 |
| EPS forecast (this quarter) | -$0.14 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$66.0M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters New York, New York |
Forecasts
